Sign in
4

Changes in Ownership

Denali Therapeutics Inc. Filed Acc 0001714899-22-000148

Director sold 20,000 shares at $30.48 ($609,600)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Tessier-Lavigne Marc Director 2022-11-23 Sale −20,000 $30.48 $609,600 1,870,356 D
Open-market sales · 20,000 sh · avg $30.48 · $609,600
Loading xslF345X03/wf-form4_166968178535428.xml…